Travere Therapeutics (TVTX) Research & Development (2012 - 2026)
Travere Therapeutics' Research & Development was $60.28 million in Q2 2026, up 22.1% from $49.36 million a year earlier and up 5.6% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Research & Development (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Travere Therapeutics' Research & Development was $227.14 million through Jun 30, 2026, up 8.2% year-over-year; for FY2025, it came in at $206.01 million, down 5.3% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- In earlier years, Research & Development was $217.5 million in FY2024 (-11.2%), $244.99 million in FY2023 (+7.8%), $227.33 million in FY2022 (+13.0%) and $201.16 million in FY2021 (+52.7%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q4 2024.
- Compared with a year earlier, Research & Development was higher in four of the last eight quarters, with growth averaging 1.6%.
- The best year-over-year quarter for Research & Development over five years was Q3 2021 (growth of 49.6%); the worst was Q2 2024 (a decline of 18.3%).
- Per Business Quant data, TVTX's Research & Development in the three quarters before Q2 2026 was $57.09 million (Q1 2026), $57.87 million (Q4 2025) and $51.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Travere Therapeutics | 4.93 Bn | 4.53 Bn | 167.41 Mn | 60.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.28 Mn |
| Mar 31, 2026 | 57.09 Mn |
| Dec 31, 2025 | 57.87 Mn |
| Sep 30, 2025 | 51.89 Mn |
| Jun 30, 2025 | 49.36 Mn |
| Mar 31, 2025 | 46.89 Mn |
| Dec 31, 2024 | 62.07 Mn |
| Sep 30, 2024 | 51.68 Mn |
| Jun 30, 2024 | 54.33 Mn |
| Mar 31, 2024 | 49.42 Mn |
| Dec 31, 2023 | 59.75 Mn |
| Sep 30, 2023 | 60.59 Mn |
| Jun 30, 2023 | 66.49 Mn |
| Mar 31, 2023 | 58.16 Mn |
| Dec 31, 2022 | 58.09 Mn |
| Sep 30, 2022 | 57.15 Mn |
| Jun 30, 2022 | 59.68 Mn |
| Mar 31, 2022 | 56.61 Mn |
| Dec 31, 2021 | 53.00 Mn |
| Sep 30, 2021 | 48.41 Mn |
API Access
Travere Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();